European Healthtech startup funding raised during 2015.
In 2015, 211 European Healthtech companies raised a combined €1.9B across 228 funding rounds. Switzerland led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 21 Aug 2026.
15 exits · €821M disclosed.
| Biotie Therapies | Acquisition | Sep 2015 | €330M |
| Dezima Pharma | Acquisition | Mar 2015 | €273M |
| WiThings | Acquisition | Dec 2015 | €170M |
| ClipFort | Acquisition | Dec 2015 | €26M |
| AMO Pharma | Buyout | Jun 2015 | €23M |
| €73M |
| ADC Therapeutics | Growth/Late | Sep 2015 | €71M |
| Symphogen | Debt | Oct 2015 | €68M |
| CRISPR Therapeutics | Series B | Apr 2015 | €59M |
| ObsEva | Series B | Nov 2015 | €54M |
| CureVac | Series D+ | Mar 2015 | €46M |
| Kymab | Series B | May 2015 | €45M |
| Sanifit | Series C | Sep 2015 | €37M |
| DNAe LTD | Debt | Nov 2015 | €35M |
| Bima | Series C | Jul 2015 | €34M |
| GenSight Biologics | Series B | Jul 2015 | €32M |
| NightstaRx | Series B | Nov 2015 | €32M |
